Apparent inhibition of active non-electrolyte transport by an increased sodium permeability of the plasma membrane. Mechanism of action of p-chloromercuribenzene sulfonate.
D002731:4-Chloromercuribenzenesulfonate / Q000494:pharmacology*; D000818:Animals; D001692:Biological Transport / Q000187:drug effects*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects*; D004229:Dithiothreitol / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D007583:Jejunum / Q000378:metabolism; D007700:Kinetics; D008871:Microvilli / Q000187:drug effects / Q000378:metabolism; D010663:Phenylmercury Compounds / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012964:Sodium / Q000378:metabolism*; D013045:Species Specificity; D013393:Sucrase / Q000378:metabolism; D014633:Valine / Q000378:metabolism
D010663:Phenylmercury Compounds; D002731:4-Chloromercuribenzenesulfonate; D012964:Sodium; D013393:Sucrase; D014633:Valine; D005947:Glucose; D004229:Dithiothreitol